US Patent Issued to Ultragenyx Pharmaceutical on Dec. 2 for "Scalable method for producing transfection reagents" (American, Swiss Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,487,152, issued on Dec. 2, was assigned to Ultragenyx Pharmaceutical Inc. (Novato, Calif.).

"Scalable method for producing transfection reagents" was invented by Jan Panteli (Cambridge, Mass.) and Ying Jing (Reinach, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides easy-to-scale methods of creating DNA/transfection reagent master mixes for transfecting cells in culture."

The patent was filed on May 9, 2018, under Application No. 16/612,002.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.h...